EUVIMED · CrossrefZeitschrift
SLAS Discovery
ISSN 2472-5552 · Elsevier BV
Neueste Artikel
Virus-like particles: An effective, efficient and accessible platform for testing antibody binding
MitoLatentProfiler: ROI-constrained deep learning for mitochondrial phenotyping in human myotubes
Decision-grade evidence for AI-enabled small-molecule discovery
High-content imaging workflow for single-cell drug response profiling of acute myeloid leukemia subtypes
From phenotypic screening to target and compound prioritization for autosomal dominant polycystic kidney disease
Patient-derived 3d cell models as new approach methodologies: Applications, advances, and challenges for increased-throughput assays
Hit selection using SSMD-based machine learning performance metrics in high-throughput screening assays
Probing and painting to get the full picture of macrophage polarisation
High-throughput discovery of actin-binding compounds for cardiac disorders
Machine learning-based brightfield detection of anti-fibrotic effects in a 3D retinal fibrosis model
Automated spheroid and organoid image analysis from rule-based methods to deep learning
Development, optimization, and validation of a TGF-β1-induced common mediator Smad4 nuclear translocation high content imaging assay
Quantitative substrate profiling of Zika NS5 methyltransferase activity
Label-free live cell analysis in transmitted light using cross-channel supervised deep learning
Tumor-versus-nonmalignant quantitative drug sensitivity profiling identifies capivasertib as a selective therapeutic candidate for nasopharyngeal carcinoma
High throughput, automated and fully contained cytokine release assay using primary human CD4+ T cells
Response to letter regarding “AI‑based analysis of label‑free live‑cell imaging of T‑cell–mediated tumor killing”
Beyond fluorescence: A critical look at AI-powered brightfield analysis for T-cell killing assays
FRET prioritization score to choose high-quality hit equity and reduce the impact of interference by quenching and fluorescence
The emerging synergy of experimental and computational approaches for therapeutic modulation of biomolecular condensates
Cleaving through complexity: Pan-serotype fluorimetric assays for the dengue virus proteases
Repurposing drug screen for the identification of helicase inhibitors from viruses of pandemic concern
A high throughput assay to identify modulators of Death Receptor 3 (DR3)
Application of a MALDI mass spectrometry assay to identify covalent fragments targeting the methyl-lysine reader protein MPP8
Binder2030: a quantitative membrane proteome binding dataset enabling AI-driven drug discovery
An ELISA for discovering protein-protein interaction inhibitors: Blocking lysinoalanine crosslinking between subunits of the spirochete flagellar hook as a test case
Streamlining cellular thermal shift assay for ultra-high throughput screening
Fluorescent probe-based detection of outer membrane damage of Gram-negative bacteria
Genetically encoded fluorogenic RNA-based bioluminescence resonance energy transfer (BRET) sensors for cellular imaging and target detection
Nanobodies: A new frontier in antiviral therapies
EUVIMED